The leadership of the Journal of Alzheimer's Disease has disclosed the following information in keeping with the journal's disclosure policy.
George Perry, PhD, Editor-in-Chief
Consultant/Advisory Boards: Alzheimer Research and Prevention Foundation, Aria, Neurotez, ACT-AD, Phoenix Biotech, Investcure
Equity Ownership/Stock Options: Neurotez, Nebulab, Neurotrope
Other: IOS Press (strategic advisor), NanoBiotech Pharma (Medical Advisory Committee)
Beth Kumar, Managing Editor
Nothing to Disclose
Jesus Avila, MD, Deputy Editor
Nothing to Disclose
Paula Moreira, PhD, Deputy Editor
Nothing to Disclose
Massimo Tabaton, MD, Deputy Editor
Nothing to Disclose
Xiongwei Zhu, PhD, Deputy Editor
Nothing to Disclose
Daniela Galimberti, PhD, Reviews Editor
Nothing to Disclose
Allyson Rosen, PhD, ABPP-CN, Ethics Editor
Nothing to Disclose
Aaron A. Sorensen, Scientometrics Editor
Other: IOS Press
Last updated 4 June 2018